Previous 10 | Next 10 |
Gainers: Infinity Pharmaceuticals (INFI) +62%, Grove (GRVI) +26%, Shineco (TYHT) +24%, Tilray TLRY +22%, NeuroMetrix (NURO) +19%.Losers: Dyadic (DYAI) -14%, EyeGate Pharmaceuticals (EYEG) -13%, NanoViricides (NNVC) -13%, Myovant Sciences MYOV&...
Zerbor/iStock via Getty Images Shares of Neurometrix ([[NURO]] -0.8%) are up this morning as results of a trial of its neurostimulation device Quell were published in a scientific journal. After three months, patients who used a standard dose of neurostimulation using the Quell device saw red...
WOBURN, Mass., July 26, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced a publication titled “Effects of Wearable Transcutaneous Electrical Nerve Stimulation on Fibromyalgia: A Randomized Controlled Trial" in the Journal of Pain Research. The article is avai...
Iterum Therapeutics plc (ITRM) -43% after announcing FDA’s Complete Response Letter for sulopenem.ATI Physical Therapy, Inc. (ATIP) -25% on Q2 earnings releaseNew Oriental Education & Technology Group Inc. (EDU) -24% provides update on new regulations.China...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks rose Friday for the fourth straight session after a rough start to the week, with most major groups moving higher despite the continue...
Gainers: Xenetic Biosciences (XBIO) +126%, Medigus (MDGS)+35%, Acorda Therapeutics (ACOR) +30%, NRx Pharmaceuticals (NRXP) +14%, Apollo Medical (AMEH) +13%.Losers: ImmunoPrecise Antibodies (IPA) -36%, Adverum Biotechnologies (ADVM) -23%,&...
Socket Mobile SCKT +79% on Q2 earningsAlzamend Neuro ALZN +62% after data showing safety of Alzheimer’s therapy in mouse studyVeoneer VNE +55% on earningsAcorda Therapeutics ACOR+49% on INBRIJA distribution and supply dealNRx Pharmaceuticals (NRXP) +5...
Are These The Best Health Care Stocks To Buy Before August 2021? The health care industry is once again in the spotlight now as the world faces an uptick in coronavirus infections. As a result, it would not surprise me to see investors eyeing the top health care stocks in the stoc...
NeuroMetrix, Inc. (NURO) Q2 2021 Results Conference Call July 22, 2021 08:00 AM ET Company Participants Thomas Higgins - Senior Vice President & Chief Financial Officer Dr. Shai Gozani - President & Chief Executive Officer Conference Call Participants Jerry Noury - Little West 12th St...
Gainers: ImmunoPrecise Antibodies (IPA) +88%, PainReform (PRFX) +48%, NRx Pharmaceuticals (NRXP) +30%, NeuroMetrix (NURO) +27%, Universe Pharmaceuticals (UPC) +18%.Losers: Seres Therapeutics (MCRB) -57%, Jupiter Wellness (JUPW)&...
News, Short Squeeze, Breakout and More Instantly...
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2024. The Company's mission is to reduce the impact of neurological disorders and pain syndromes through innovative non-invasive medica...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...